Canada Life’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,689
Closed -$12K 2471
2022
Q1
$12K Hold
1,689
﹤0.01% 2421
2021
Q4
$28K Hold
1,689
﹤0.01% 2314
2021
Q3
$49K Hold
1,689
﹤0.01% 2242
2021
Q2
$59K Sell
1,689
-807
-32% -$25.6K ﹤0.01% 2219
2021
Q1
$78K Hold
2,496
﹤0.01% 2165
2020
Q4
$118K Hold
2,496
﹤0.01% 2078
2020
Q3
$116K Hold
2,496
﹤0.01% 2011
2020
Q2
$90K Buy
+2,496
New +$91.9K ﹤0.01% 2072

Other funds holding ZYME

Canada Life's ZYME Position: Q2 2022 in Review

Canada Life sold out of Zymeworks (ZYME) in Q2 2022, closing a stake of 1,689 shares — an estimated $12K sold.

Canada Life first reported a position in ZYME in Q2 2020 and held it in 8 quarters. The position peaked at $118K in Q4 2020. 113 funds tracked by Wall St. Rank hold ZYME as of Q2 2022.

  • Canada Life reported no remaining Zymeworks position as of Q2 2022 after selling out during the quarter.
  • Canada Life sold 1,689 Zymeworks shares in Q2 2022, an estimated $12K.
  • Canada Life first reported a position in Zymeworks in Q2 2020 and held it in 8 quarters.
  • Canada Life's Zymeworks position peaked at $118K in Q4 2020.
  • 113 funds tracked by Wall St. Rank held Zymeworks as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.